Noxopharm
(ASX) NOX
Noxopharm Financials at a Glance
Market Cap
$17.82M
Revenue (TTM)
$4.01M
Net Income (TTM)
$7.81M
EPS (TTM)
$-0.02
P/E Ratio
-3.09
Dividend
$0.00
Beta (Volatility)
0.03 (Low)
Dividend
$0.00
Beta (Volatility)
0.03 (Low)
Price
$0.06
Volume
19,422
Open
$0.06
Price
$0.06
Volume
19,422
Open
$0.06
Previous Close
$0.06
Daily Range
$0.06 - $0.06
52-Week Range
$0.04 - $0.14
Dividend
$0.00
Beta (Volatility)
0.03 (Low)
Price
$0.06
Volume
19,422
Open
$0.06
Previous Close
$0.06
Daily Range
$0.06 - $0.06
52-Week Range
$0.04 - $0.14
NOX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Noxopharm
Industry
Biotechnology
Sector
Health CareCEO
Gisela Mautner, MD, PhD
Website
www.noxopharm.comHeadquarters
Chatswood, NSW 2067, AU
NOX Financials
Key Financial Metrics (TTM)
Gross Margin
-63%
Operating Margin
-5%
Net Income Margin
-3%
Return on Equity
-344%
Return on Capital
8%
Return on Assets
-1%
Earnings Yield
-32.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$17.82M
Shares Outstanding
307.24M
Volume
19.42K
Short Interest
0.00%
Avg. Volume
163.31K
Financials (TTM)
Gross Profit
$1.45M
Operating Income
$9.65M
EBITDA
$5.38M
Operating Cash Flow
$5.82M
Capital Expenditure
$0.00
Free Cash Flow
$5.82M
Cash & ST Invst.
$1.55M
Total Debt
$2.48M
Noxopharm Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$879.00
-100.1%
Gross Margin
0.00%
N/A
Market Cap
$17.82M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$1.84M
+26.3%
EBITDA
$3.02M
+18.0%
Quarterly Fundamentals
Net Cash
$4.15M
-180.5%
Accounts Receivable
$4.61M
+287.9%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$4.25M
N/A
Return on Assets
-1.16%
N/A
Return on Invested Capital
7.98%
N/A
Free Cash Flow
$4.56M
+44.6%
Operating Cash Flow
$4.56M
+44.6%